NEW HAVEN — The financial costs of the COVID-19 pandemic have forced Yale New Haven Health System to delay its neurosciences building along with its other major projects, CEO Marna Borgstrom said Wednesday.
The $838 million project, which is planned for Yale New Haven Hospital’s St. Raphael campus off George Street, received approval from the City Plan Commission on April 15. The decision also delays a new cancer cener at Greenwich Hospital.
“The losses that are being experienced in hospital-based health care are staggering and ours are no exception,” Borgstrom said during the weekly online press conference.
“Even with the federal moneys that have been approved … they aren’t enough to bring us back to where we were before. So a big part of what we’re all going to be dealing with is figuring out how to reintroduce our businesses and reintroduce greater financial stability in our health system. We have major investments in Greenwich in an extension of the Smilow Cancer Center. In New Haven, we’ve put a hold on a big neurosciences project. You can’t just go back and begin business as usual.”
Research in the neuroscience building would focus on Parkinson’s disease, amyotrophic lateral sclerosis, multiple sclerosis and stroke. The hospital has estimated that the project will contribute more than $1 billion to the state economy as it is built over the next five years.
Yale New Haven spokesman Vincent Petrini issued a statement after the press conference, stating, “We have put all major projects on hold as we care for patients impacted by the COVID pandemic, which is our most important priority at this point. While we had hoped to break ground for the project within the next couple of months, and we are very appreciative of the city’s support, we are in the midst of assessing the financial impact of responding to the pandemic and that will ultimately impact timing of the project.”
Petrini said furloughs of health system employees are not being considered “at this point.” On Tuesday, Stamford Health furloughed 375 employees who are not involved in direct patient care.